Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-22-034557
Filing Date
2022-09-23
Accepted
2022-09-23 18:00:58
Documents
2
Period of Report
2022-09-16

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1434
2 EXHIBIT 24 brhc10042187_ex24.htm EX-24 5953
  Complete submission text file 0001140361-22-034557.txt   8741
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MYOVANT SCIENCES INC. 2000 SIERRA POINT PARKWAY BRISBANE CA 94005
Business Address
Nomura Hiroshi (Reporting) CIK: 0001798096 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40782 | Film No.: 221263204